Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients (Q37532488)

20 August 2017

Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients (English)

1 reference

20 August 2017

1 reference

Jason C Gallagher

1

1 reference

20 August 2017

Mirza E Perez

2

1 reference

20 August 2017

Elizabeth A Marino

3

1 reference

20 August 2017

Laura G LoCastro

4

1 reference

20 August 2017

Lauren A Abrardo

5

1 reference

20 August 2017

Conan MacDougall

6

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

20 August 2017

1 reference

20 August 2017

29

1 reference

20 August 2017

7

1 reference

20 August 2017

792-799

1 reference

Vancomycin-resistant enterococci

20 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

New antimicrobial agents for the treatment of Gram-positive bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Tigecycline: a new glycylcycline for treatment of serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Optimizing therapy for vancomycin-resistant enterococci (VRE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.7.792

21 January 2018

Identifiers

DOI

10.1592/PHCO.29.7.792

1 reference

20 August 2017

1 reference